共查询到20条相似文献,搜索用时 15 毫秒
1.
Shakeel U. R. Mir Nicholas M. George Lubna Zahoor Robert Harms Zachary Guinn Nora E. Sarvetnick 《The Journal of biological chemistry》2015,290(10):6071-6085
Autophagy, a cellular recycling process responsible for turnover of cytoplasmic contents, is critical for maintenance of health. Defects in this process have been linked to diabetes. Diabetes-associated glucotoxicity/lipotoxicity contribute to impaired β-cell function and have been implicated as contributing factors to this disease. We tested the hypothesis that these two conditions affect β-cell function by modulating autophagy. We report that exposure of β-cell lines and human pancreatic islets to high levels of glucose and lipids blocks autophagic flux and leads to apoptotic cell death. EM analysis showed accumulation of autophagy intermediates (autophagosomes), with abundant engulfed cargo in palmitic acid (PA)- or glucose-treated cells, indicating suppressed autophagic turnover. EM studies also showed accumulation of damaged mitochondria, endoplasmic reticulum distention, and vacuolar changes in PA-treated cells. Pulse-chase experiments indicated decreased protein turnover in β-cells treated with PA/glucose. Expression of mTORC1, an inhibitor of autophagy, was elevated in β-cells treated with PA/glucose. mTORC1 inhibition, by treatment with rapamycin, reversed changes in autophagic flux, and cell death induced by glucose/PA. Our results indicate that nutrient toxicity-induced cell death occurs via impaired autophagy and is mediated by activation of mTORC1 in β-cells, contributing to β-cell failure in the presence of metabolic stress. 相似文献
2.
Nina Stemmer Elena Strekalova Nevena Djogo Frank Pl?ger Gabriele Loers David Lutz Friedrich Buck Marek Michalak Melitta Schachner Ralf Kleene 《PloS one》2013,8(4)
Dysregulation of the proteolytic processing of amyloid precursor protein by γ-secretase and the ensuing generation of amyloid-β is associated with the pathogenesis of Alzheimer''s disease. Thus, the identification of amyloid precursor protein binding proteins involved in regulating processing of amyloid precursor protein by the γ-secretase complex is essential for understanding the mechanisms underlying the molecular pathology of the disease. We identified calreticulin as novel amyloid precursor protein interaction partner that binds to the γ-secretase cleavage site within amyloid precursor protein and showed that this Ca2+- and N-glycan-independent interaction is mediated by amino acids 330–344 in the C-terminal C-domain of calreticulin. Co-immunoprecipitation confirmed that calreticulin is not only associated with amyloid precursor protein but also with the γ-secretase complex members presenilin and nicastrin. Calreticulin was detected at the cell surface by surface biotinylation of cells overexpressing amyloid precursor protein and was co-localized by immunostaining with amyloid precursor protein and presenilin at the cell surface of hippocampal neurons. The P-domain of calreticulin located between the N-terminal N-domain and the C-domain interacts with presenilin, the catalytic subunit of the γ-secretase complex. The P- and C-domains also interact with nicastrin, another functionally important subunit of this complex. Transfection of amyloid precursor protein overexpressing cells with full-length calreticulin leads to a decrease in amyloid-β42 levels in culture supernatants, while transfection with the P-domain increases amyloid-β40 levels. Similarly, application of the recombinant P- or C-domains and of a synthetic calreticulin peptide comprising amino acid 330–344 to amyloid precursor protein overexpressing cells result in elevated amyloid-β40 and amyloid-β42 levels, respectively. These findings indicate that the interaction of calreticulin with amyloid precursor protein and the γ-secretase complex regulates the proteolytic processing of amyloid precursor protein by the γ-secretase complex, pointing to calreticulin as a potential target for therapy in Alzheimer''s disease. 相似文献
3.
4.
Patricia Spilman Natalia Podlutskaya Matthew J. Hart Jayanta Debnath Olivia Gorostiza Dale Bredesen Arlan Richardson Randy Strong Veronica Galvan 《PloS one》2010,5(4)
Background
Reduced TOR signaling has been shown to significantly increase lifespan in a variety of organisms [1], [2], [3], [4]. It was recently demonstrated that long-term treatment with rapamycin, an inhibitor of the mTOR pathway[5], or ablation of the mTOR target p70S6K[6] extends lifespan in mice, possibly by delaying aging. Whether inhibition of the mTOR pathway would delay or prevent age-associated disease such as AD remained to be determined.Methodology/Principal Findings
We used rapamycin administration and behavioral tools in a mouse model of AD as well as standard biochemical and immunohistochemical measures in brain tissue to provide answers for this question. Here we show that long-term inhibition of mTOR by rapamycin prevented AD-like cognitive deficits and lowered levels of Aβ42, a major toxic species in AD[7], in the PDAPP transgenic mouse model. These data indicate that inhibition of the mTOR pathway can reduce Aβ42 levels in vivo and block or delay AD in mice. As expected from the inhibition of mTOR, autophagy was increased in neurons of rapamycin-treated transgenic, but not in non-transgenic, PDAPP mice, suggesting that the reduction in Aβ and the improvement in cognitive function are due in part to increased autophagy, possibly as a response to high levels of Aβ.Conclusions/Significance
Our data suggest that inhibition of mTOR by rapamycin, an intervention that extends lifespan in mice, can slow or block AD progression in a transgenic mouse model of the disease. Rapamycin, already used in clinical settings, may be a potentially effective therapeutic agent for the treatment of AD. 相似文献5.
Hyeon-Joong Kim Eun-Joo Shin Byung-Hwan Lee Sun-Hye Choi Seok-Won Jung Ik-Hyun Cho Sung-Hee Hwang Joon Yong Kim Jung-Soo Han ChiHye Chung Choon-Gon Jang Hyewon Rhim Hyoung-Chun Kim Seung-Yeol Nah 《Molecules and cells》2015,38(9):796-805
Gintonin is a novel ginseng-derived lysophosphatidic acid (LPA) receptor ligand. Oral administration of gintonin ameliorates learning and memory dysfunctions in Alzheimer’s disease (AD) animal models. The brain cholinergic system plays a key role in cognitive functions. The brains of AD patients show a reduction in acetylcholine concentration caused by cholinergic system impairments. However, little is known about the role of LPA in the cholinergic system. In this study, we used gintonin to investigate the effect of LPA receptor activation on the cholinergic system in vitro and in vivo using wild-type and AD animal models. Gintonin induced [Ca2+]i transient in cultured mouse hippocampal neural progenitor cells (NPCs). Gintonin-mediated [Ca2+]i transients were linked to stimulation of acetylcholine release through LPA receptor activation. Oral administration of gintonin-enriched fraction (25, 50, or 100 mg/kg, 3 weeks) significantly attenuated scopolamine-induced memory impairment. Oral administration of gintonin (25 or 50 mg/kg, 2 weeks) also significantly attenuated amyloid-β protein (Aβ)-induced cholinergic dysfunctions, such as decreased acetylcholine concentration, decreased choline acetyltransferase (ChAT) activity and immunoreactivity, and increased acetylcholine esterase (AChE) activity. In a transgenic AD mouse model, long-term oral administration of gintonin (25 or 50 mg/kg, 3 months) also attenuated AD-related cholinergic impairments. In this study, we showed that activation of G protein-coupled LPA receptors by gintonin is coupled to the regulation of cholinergic functions. Furthermore, this study showed that gintonin could be a novel agent for the restoration of cholinergic system damages due to Aβ and could be utilized for AD prevention or therapy. 相似文献
6.
Aggregation of amyloid-β (Aβ) peptide, a 39- to 43-residue fragment of the amyloid precursor protein, is associated with Alzheimer's disease, the most common form of dementia in the elderly population. Several experimental studies have tried to characterize the atomic details of amyloid fibrils, which are the final product of Aβ aggregation. Much less is known about species forming during the early stages of aggregation, in particular about the monomeric state of the Aβ peptide that may be viewed as the product of the very first step in the hypothesized amyloid cascade. Here, the equilibrium ensembles of monomeric Aβ alloforms Aβ1-40 and Aβ1-42 are investigated by Monte Carlo simulations using an atomistic force field and implicit solvent model that have been shown previously to correctly reproduce the ensemble properties of other intrinsically disordered polypeptides.Our simulation results indicate that at physiological temperatures, both alloforms of Aβ assume a largely collapsed globular structure. Conformations feature a fluid hydrophobic core formed, on average, by contacts both within and between the two segments comprising residues 12-21 and 24-40/42, respectively. Furthermore, the 11 N-terminal residues are completely unstructured, and all charged side chains, in particular those of Glu22 and Asp23, remain exposed to solvent. Taken together, these observations indicate a micelle-like† architecture at the monomer level whose implications for oligomerization, as well as fibril formation and elongation, are discussed. We establish quantitatively the intrinsic disorder of Aβ and find the propensity to form regular secondary structure to be low but sequence specific. In the presence of a global and unspecific bias for backbone conformations to populate the β-basin, the β-sheet propensity along the sequence is consistent with the arrangement of the monomer within the fibril, as derived from solid-state NMR data. These observations indicate that the primary sequence partially encodes fibril structure, but that fibril elongation must be thought of as a templated assembly step. 相似文献
7.
Li Tao Fangtian Fan Yuping Liu Weidong Li Lei Zhang Junshan Ruan Cunsi Shen Xiaobo Sheng Zhijie Zhu Aiyun Wang Wenxing Chen Shile Huang Yin Lu 《PloS one》2013,8(11)
Xanthatin, a sesquiterpene lactone purified from Xanthium strumarium L., possesses prominent anticancer activity. We found that disruption of GSK3β activity was essential for xanthatin to exert its anticancer properties in non-small cell lung cancer (NSCLC), concurrent with preferable suppression of constitutive activation of STAT3. Interestingly, inactivation of the two signals are two mutually exclusive events in xanthatin-induced cell death. Moreover, we surprisingly found that exposure of xanthatin failed to trigger the presumable side effect of canonical Wnt/β-Catenin followed by GSK3β inactivation. We further observed that the downregulation of STAT3 was required for xanthatin to fine-tune the risk. Thus, the discovery of xanthatin, which has ability to simultaneously orchestrate two independent signaling cascades, may have important implications for screening promising drugs in cancer therapies. 相似文献
8.
Abdullah Sultan Bakthisaran Raman Ch. Mohan Rao Ramakrishna Tangirala 《The Journal of biological chemistry》2013,288(45):32326-32342
Fibril formation of β2-microglobulin and associated inflammation occur in patients on long term dialysis. We show that the plasma protein haptoglobin prevents the fatty acid-promoted de novo fibril formation of β2-microglobulin even at substoichiometric concentration. The fibrils are cytotoxic, and haptoglobin abolishes the cytotoxicity by preventing fibril formation. Haptoglobin does not alleviate the cytotoxicity of preformed fibrils. Fibrillar β2-microglobulin is resistant to lysosomal degradation. However, the species of β2-microglobulin populated in the presence of haptoglobin is susceptible to degradation. We observed that haptoglobin interacts with oligomeric prefibrillar species of β2-microglobulin but not with monomeric or fibrillar β2-microglobulin that may underlie the molecular mechanism. 1,1′-Bis(4-anilino)naphthalene-5,5′-disulfonic acid cross-linking to haptoglobin significantly compromises its chaperone activity, suggesting the involvement of hydrophobic surfaces. Haptoglobin is an acute phase protein whose level increases severalfold during inflammation, where local acidosis can occur. Our data show that haptoglobin prevents fibril formation of β2-microglobulin under conditions of physiological acidosis (between pH 5.5 and 6.5) but with relatively decreased efficiency. However, compromise in its chaperone activity under these conditions is more than compensated by its increased level of expression under inflammation. Erythrolysis is known to release hemoglobin into the plasma. Haptoglobin forms a 1:1 (mol/mol) complex with hemoglobin. This complex, like haptoglobin, interacts with the prefibrillar species of β2-microglobulin, preventing its fibril formation and the associated cytotoxicity and resistance to intracellular degradation. Thus, our study demonstrates that haptoglobin is a potential extracellular chaperone for β2-microglobulin even in moderately acidic conditions relevant during inflammation, with promising therapeutic implications in β2-microglobulin amyloid-related diseases. 相似文献
9.
10.
Markus P. Kummer Hiroko Maruyama Claudia Huelsmann Sandra Baches Sascha Weggen Edward H. Koo 《The Journal of biological chemistry》2009,284(4):2296-2306
The formation of insoluble cross β-sheet amyloid is pathologically
associated with disorders such as Alzheimer, Parkinson, and Huntington
diseases. One exception is the nonpathological amyloid derived from the
protein Pmel17 within melanosomes to generate melanin pigment. Here we show
that the formation of insoluble MαC intracellular fragments of Pmel17,
which are the direct precursors to Pmel17 amyloid, depends on a novel
juxtamembrane cleavage at amino acid position 583 between the furin-like
proprotein convertase cleavage site and the transmembrane domain. The
resulting Pmel17 C-terminal fragment is then processed by the
γ-secretase complex to release a short-lived intracellular domain
fragment. Thus, by analogy to the Notch receptor, we designate this cleavage
the S2 cleavage site, whereas γ-secretase mediates proteolysis at the
intramembrane S3 site. Substitutions or deletions at this S2 cleavage site,
the use of the metalloproteinase inhibitor TAPI-2, as well as small
interfering RNA-mediated knock-down of the metalloproteinases ADAM10 and 17
reduced the formation of insoluble Pmel17 fragments. These results demonstrate
that the release of the Pmel17 ectodomain, which is critical for melanin
amyloidogenesis, is initiated by S2 cleavage at a juxtamembrane position.Folding of proteins is a highly regulated process ensuring their correct
three-dimensional structure. Under pathological circumstances, a soluble
protein can be folded into highly stable cross β-sheet amyloid
structures, which are believed to play pathological roles in disorders such as
Alzheimer, Parkinson, and Huntington diseases. An exception to this general
concept is the physiological amyloid structure of the melanosomal matrix
formed by the protein Pmel17. Melanosomes are lysosome-related organelles that
contain pigment granules (melanin) in melanocytes and retinal epithelial cells
(reviewed in Ref. 1).
Melanogenesis is believed to proceed through several sequential maturation
steps, classified by melanosomes from stage I to stage IV. Maturation of stage
II melanosomes requires the formation of Pmel17 intralumenal fibers
(2,
3).Pmel17 (also called gp100, ME20, RPE1, or silver) is a type I transmembrane
glycoprotein of up to 668 amino acids in humans (reviewed in Ref.
4). The requirement of Pmel17
for the generation of functional melanin has been shown in a number of
different organisms, because, for example, certain point mutations in the
Pmel17/silver gene result in hypopigmentation phenotypes
(5–7).
The most characteristic domain within Pmel17 is a specific lumenal
proline/serine/threonine rich repeat domain (see
Fig. 1A), that is
imperfectly repeated 13 times in the Mα fragment. Importantly, deletion
of the rich repeat domain results in a complete loss of fibril formation,
pointing to the requirement of Pmel17, and especially the rich repeat domain,
in melanin formation (8).
Pmel17 exists in different isoforms generated by alternative splicing.
Pmel17-i2 is the most
abundant isoform, whereas the Pmel17-l isoform contains a 7-amino acid
insertion close to the transmembrane domain
(9,
10).Open in a separate windowFIGURE 1.Effect of the γ-secretase inhibitor DAPT on Pmel17 processing.
A, schematic diagram of Pmel17 and epitopes of antibodies. Pmel17
contains five potential N-glycosylation sites indicated by branched
structures. The long form of Pmel17, Pmel17-l, is characterized by a seven
amino acid insertion (VPGILLT) within the lumenal domain close to the
transmembrane domain (TM), which is absent in Pmel17-i. NVS marks a
potential N-glycosylation site near this insertion. The epitopes of
antibodies αPep13h and HMB45 are indicated. Cleavage by a furin-like PC
results in the formation of the Mα and the membrane-bound 26-kDa Mβ
fragment, which are connected via disulfide bonds. Release and further
processing of the Mα fragment into MαN and MαC fragments
results in the formation of fibrils and marks the transition of stage I to
stage II melanosomes (dashed line). B, human MNT-1 cells
were incubated with increasing amounts of DAPT for 18 h, and then the lysates
were separated by SDS-PAGE and analyzed by immunoblotting with αPep13h
antibody. DAPT treatment resulted in the accumulation of a C-terminal fragment
of Pmel17 (CTF), whereas Pmel17 P1 and Mβ fragment were unchanged.
C, probing the Triton-soluble fraction with HMB45 revealed increased
amounts of the highly glycosylated P2 form of Pmel17 after DAPT incubation.
D, detection of Pmel17 amyloidogenic fragments (MαC) in the
SDS-extracted insoluble pellet using antibody HMB45. E, murine B16-FO
cells treated with increasing concentrations of DAPT. Immunoblotting using
antibodyαPep13h revealed the formation of CTF of similar size as in
MNT-1 cells. F, time course analysis of Pmel17, Mβ, and
Pmel17-CTF after DAPT treatment. The cell lysates were immunoblotted using
αPep13h. Pmel17-CTF was detectable after 10 min of incubation with 1
μm DAPT. G, the size of the Pmel17-CTF was determined
using an unstained low molecular range peptide standard. The marker peptides
were detected by Ponceau S staining and Pmel17-CTF were detected by immunoblot
using αPep13h.Pmel17 traffics through the secretory pathway as a 100-kDa protein (called
P1). In the late Golgi compartment it undergoes further glycosylation,
resulting in a short lived 120-kDa protein (called P2). P2 is rapidly cleaved
within the post-Golgi by a furin-like proprotein convertase (PC) to generate
two fragments that remain tethered to each other by disulfide bonds: a
C-terminal polypeptide containing the transmembrane domain (Mβ) and a
large N-terminal ectodomain (Mα)
(2)
(Fig. 1A).
Consequently, inhibition of this furin-like activity not only prevents the
generation of Mα and Mβ fragments but also inhibits the formation
of melanosomal striation in HeLa cells
(3). These findings suggest
that Mα must first be dissociated from the Mβ for melanogenesis to
proceed. It is unclear how Mα is released from the membrane. Reduction
of disulfide bonds would release Mα from Mβ; alternatively,
proteolytic digestion of Mβ should also free Mα from the membrane
tether. It has been speculated that, given the presence of lysosomal
hydrolases in melanosomes and proteolytic maturation of Pmel17, proteolysis is
the more likely mechanism (4).
Recently, it was shown that recombinant Mα is able to form amyloid
structures in vitro in an unprecedented rapidity, and furthermore,
Pmel17 amyloid also accelerated melanin formation
(11). These findings
demonstrate that mammalian amyloid formed by Pmel17 is functional and
physiological.The insoluble pool of Pmel17 in cells consists mostly of truncated Mα
C-terminal fragments (MαC) of heterogeneous sizes, indicating that
further processing of Mα occurs after its release from the membrane
(8,
12). MαC fragments are
found in the insoluble fraction of melanocytes as well as in nonmelanotic
cells, the latter after overexpression of Pmel17
(8), and are reduced or absent
in amelanotic cells (8,
13,
14). Meanwhile, the C-terminal
fragment derived from the Mβ fragment and recognized by a C-terminal
specific epitope antibody is less stable, indicating rapid turnover
(2).The presenilin (PS) family of proteins consists of two homologous integral
transmembrane proteins, PS1 and PS2, which are part of the γ-secretase
complex. The latter consists of presenilin 1 or 2, nicastrin, APH-1, and PEN-2
(15) and catalyzes the
cleavage of the hydrophobic transmembrane domain of a burgeoning list of
proteins, also called regulated intramembrane cleavage. Other substrates for
the γ-secretase-mediated intramembrane cleavage include Notch, amyloid
precursor protein (APP), cadherin (E-cadherin), nectin-1, the low density
lipoprotein-related receptor, CD44, ErbB-4, the voltage-gated sodium channel
β2-subunit, and the Notch ligands Delta and Jagged. Importantly, in
Alzheimer disease, the presenilin-mediated γ-secretase cleavage of APP
releases the amyloid β-protein fragment, a peptide believed to play a key
role in Alzheimer disease pathogenesis. Interestingly, a recent report
described the absence of melanin pigment in presenilin-deficient animals, an
observation confirmed by the lack of melanin formation in cells treated with
γ-secretase inhibitors
(16). The mechanism
responsible for this finding is unclear, leading us to ask whether Pmel17
processing is a presenilin-dependent process and, if so, whether this cleavage
is involved in melanogenesis.In this study, we show the presence of an endoproteolytic activity that
cleaves the extracellular domain of Pmel17-i at a juxtamembrane position
between the known PC cleavage site and the transmembrane domain, which we term
the S2 cleavage site, by a TAPI-sensitive ADAM (a disintegrin
and metalloproteinase protein) protease. This
intracellular shedding of Pmel17 after S2 cleavage results in the liberation
of the Mα N-terminal ectodomain, the precursor to Pmel17 amyloid, which
is able to form insoluble Pmel17 aggregates. The C-terminal transmembrane
fragment generated by S2 cleavage is further processed by γ-secretase
(S3 cleavage) to release the Pmel17 intracellular domain, which is then
rapidly degraded. 相似文献
11.
Neurochemical Research - Alzheimer’s disease (AD) is a common neurodegenerative disease, always clinically manifesting with memory loss and other cognitive abilities serious enough to... 相似文献
12.
13.
Mohammadghasemi Vida Siavash Moghaddam Sina Rahimi Amir Pourakbar Latifeh Popović-Djordjević Jelena 《Journal of Plant Growth Regulation》2021,40(4):1714-1727
Journal of Plant Growth Regulation - Dragon’s head is a multifunctional plant with diverse applications so that all its parts, including its leaves and seeds, have nutritional value. For the... 相似文献
14.
《化学与生物多样性》2018,15(1)
Pinus armandii is suspicious to be responsible for the Pine Nut Syndrome, a long lasting bitter and metallic taste after the consumption of pine nuts. To find chemical characteristic features for the differentiation of P. armandii from other Pinus species, 41 seed samples of the genus Pinus from 22 plant species were investigated regarding the content and the composition of fatty acids, tocopherols, and amino acids. The predominant fatty acids in the seed oils were linoleic acid (35.2 – 58.2 g/100 g), oleic acid (14.6 – 48.5 g/100 g), and pinolenic acid (0.2 – 22.4 g/100 g), while the vitamin‐E‐active compounds were dominated by γ‐tocopherol. The amino acid composition was mainly characterized by arginine and glutamic acid with amounts between 0.9 and 8.9 g/100 g as well as 2.1 g/100 g and 8.3 g/100 mg. On the basis of this investigation, a Principle Component Analysis has been used to identify the most important components for the differentiation of P. armandii from other Pinus species. Using the data for glutamic acid, 20:2Δ5,11, 18:3Δ5,9,12, 18:1Δ9, and oil content, a classification of the 41 samples into four different groups by cluster analysis was possible, but the characteristic features of P. armandii were too close to some other members of the genus Pinus, making a clear differentiation of this species difficult. Nevertheless, the investigation showed the similarities of different members of the genus Pinus with regard to fatty acids, vitamin‐E‐active compounds, and amino acids. 相似文献
15.
Laura del Barrio Manoranjan Sahoo Louis Lantier Joseph M. Reynolds Ivonne Ceballos-Olvera Fabio Re 《PLoS pathogens》2015,11(3)
The role of IL-1β and IL-18 during lung infection with the gram-negative bacterium Francisella tularensis LVS has not been characterized in detail. Here, using a mouse model of pneumonic tularemia, we show that both cytokines are protective, but through different mechanisms. Il-18-/- mice quickly succumb to the infection and showed higher bacterial burden in organs and lower level of IFNγ in BALF and serum compared to wild type C57BL/6J mice. Administration of IFNγ rescued the survival of Il-18-/- mice, suggesting that their decreased resistance to tularemia is due to inability to produce IFNγ. In contrast, mice lacking IL-1 receptor or IL-1β, but not IL-1α, appeared to control the infection in its early stages, but eventually succumbed. IFNγ administration had no effect on Il-1r1-/- mice survival. Rather, Il-1r1-/- mice were found to have significantly reduced titer of Ft LPS-specific IgM. The anti-Ft LPS IgM was generated in a IL-1β-, TLR2-, and ASC-dependent fashion, promoted bacteria agglutination and phagocytosis, and was protective in passive immunization experiments. B1a B cells produced the anti-Ft LPS IgM and these cells were significantly decreased in the spleen and peritoneal cavity of infected Il-1b-/- mice, compared to C57BL/6J mice. Collectively, our results show that IL-1β and IL-18 activate non-redundant protective responses against tularemia and identify an essential role for IL-1β in the rapid generation of pathogen-specific IgM by B1a B cells. 相似文献
16.
《Autophagy》2013,9(6):620-622
Upregulation of autophagy may have therapeutic benefit in a range of diseases that include neurodegenerative conditions caused by intracytosolic aggregate-prone proteins, such as Huntington’s disease, and certain infectious diseases, such as tuberculosis. The best-characterized drug that enhances autophagy is rapamycin, an inhibitor of the TOR (target of rapamycin) proteins, which are widely conserved from yeast to man. Unfortunately, the side effects of rapamycin, especially immunosuppression, preclude its use in treating certain diseases including tuberculosis, which accounts for approximately 2 million deaths worldwide each year, spurring interest in finding novel drugs that selectively enhance autophagy. We have recently reported a novel two-step screening process for the discovery of such compounds. We first identified compounds that enhance the growth-inhibitory effects of rapamycin in the budding yeast Saccharomyces cerevisiae, which we termed small molecule enhancers of rapamycin (SMERs). Next we showed that three SMERs induced autophagy independently, or downstream of mTOR, in mammalian cells, and furthermore enhanced the clearance of a mutant huntingtin fragment in cell disease models. These SMERs also protected against mutant huntingtin fragment toxicity in Drosophila. We have subsequently tested two of the SMERs in models of tuberculosis and both enhance the killing of mycobacteria by primary human macrophages.Addendum to:Small Molecules Enhance Autophagy and Reduce Toxicity in Huntington's Disease ModelsS. Sarkar, E.O. Perlstein, S. Imarisio, S. Pineau, A. Cordenier, R.L. Maglathlin, J.A. Webster, T.A. Lewis, C.J. O'Kane, S.L. Schreiber and D.C. RubinszteinNat Chem Biol 2007; 3:331-8 相似文献
17.
Arthur Camerman H.Warren Smith Norman Camerman 《Biochemical and biophysical research communications》1978,83(1):87-93
The crystal and molecular structures of 1-[3-chloro-4-(-dimethylcarbamoylbenzyloxy)] phenyl-4,6-diamino-1,2-dihydro-2,2-dimethyl--triazine ethanesulfonate, (Baker's antifol), and 1-[4-(N-[3′-methyl-4′-fluorosulfonyl] phenyl) propanamide] phenyl-4,6-diamino-1,2-dihydro-2,2-dimethyl--triazine ethanesulfonate dihydrate (insoluble Baker's antifol) have been determined by X-ray crystallography. These compounds are, respectively, reversible and irreversible inhibitors of dihydrofolate reductase and show clinical promise for use in cancer chemotherapy. Both molecules adopt an extended conformation and are protonated at one of the triazine ring nitrogens. 相似文献
18.
Yifan Zhao Feng Ye Jian Xu Qinghong Liao Lei Chen Weijia Zhang Haopeng Sun Wenyuan Liu Feng Feng Wei Qu 《Bioorganic & medicinal chemistry》2018,26(13):3812-3824
To develop potent multi-target ligands against Alzheimer's disease (AD), a series of novel bivalent β-carboline derivatives were designed, synthesized, and evaluated. In vitro studies revealed these compounds exhibited good multifunctional activities. In particular, compounds 8f and 8g showed the good selectivity potency on BuChE inhibition (IC50?=?1.7 and 2.7?μM, respectively), Aβ1-42 disaggregation and neuroprotection. Compared with the positive control resveratrol, 8f and 8g showed better activity in inhibiting Aβ1-42 aggregation, with inhibitory rate 82.7% and 85.7% at 25?μM, respectively. Moreover, compounds 8e, 8f and 8g displayed excellent neuroprotective activity by ameliorating the impairment induced by H2O2, okadaic acid (OA) and Aβ1-42 without cytotoxicity in SH-SY5Y cells. Thus, the present study evidently showed that compounds 8f and 8g are potent multi-functional agents against AD and might serve as promising lead candidates for further development. 相似文献
19.
Chunling Yuan Xiaoli Guo Qifan Zhou Fangyu Du Wei Jiang Xiaoyu Zhou Peng Liu Tianyan Chi Xuefei Ji Jinheng Gao Chengwen Chen Hongli Lang Jia Xu Danyang Liu Yang Yang Shimeng Qiu Xing Tang Guoliang Chen Libo Zou 《生物化学与生物物理学报:疾病的分子基础》2019,1865(1):161-180
The pathogenesis of Alzheimer's disease (AD) is complex, though the clinical failures of anti-AD candidates targeting Aβ production (such as β- and γ-secretase inhibitors) make people suspect the Aβ hypothesis, in which the neurotoxicity of Aβ is undoubtedly involved. According to studies, >95% of AD patients with sporadic AD are primarily associated with abnormal Aβ clearance. Therefore, drugs that increase Aβ clearance are becoming new prospects for the treatment of AD. Here, the novel small molecule OAB-14, designed using bexarotene as the lead compound, significantly alleviated cognitive impairments in amyloid precursor protein (APP)/presenilin 1 (PS1) transgenic mice after administration for 15?days or 3?months. OAB-14 rapidly cleared 71% of Aβ by promoting microglia phagocytosis and increasing IDE and NEP expression. This compound also attenuated the downstream pathological events of Aβ accumulation, such as synaptic degeneration, neuronal loss, tau hyperphosphorylation and neuroinflammation in APP/PS1 mice. Moreover, OAB-14 had no significant effect on body weight or liver toxicity after acute and chronic treatment. OAB-14 was well tolerated and its maximum-tolerated dose in mice was >4.0?g/kg. Based on these findings, OAB-14 represents a promising new candidate for AD treatment. 相似文献
20.
Roger L. Papke Nicole A. Horenstein Abhijit R. Kulkarni Clare Stokes Lu W. Corrie Cheol-Young Maeng Ganesh A. Thakur 《The Journal of biological chemistry》2014,289(7):4515-4531
GAT107, the (+)-enantiomer of racemic 4-(4-bromophenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide, is a strong positive allosteric modulator (PAM) of α7 nicotinic acetylcholine receptor (nAChR) activation by orthosteric agonists with intrinsic allosteric agonist activities. The direct activation produced by GAT107 in electrophysiological studies is observed only as long as GAT107 is freely diffusible in solution, although the potentiating activity primed by GAT107 can persist for over 30 min after drug washout. Direct activation is sensitive to α7 nAChR antagonist methyllycaconitine, although the primed potentiation is not. The data are consistent with GAT107 activity arising from two different sites. We show that the coupling between PAMs and the binding of orthosteric ligands requires tryptophan 55 (Trp-55), which is located at the subunit interface on the complementary surface of the orthosteric binding site. Mutations of Trp-55 increase the direct activation produced by GAT107 and reduce or prevent the synergy between allosteric and orthosteric binding sites, so that these mutants can also be directly activated by other PAMs such as PNU-120596 and TQS, which do not activate wild-type α7 in the absence of orthosteric agonists. We identify Tyr-93 as an essential element for orthosteric activation, because Y93C mutants are insensitive to orthosteric agonists but respond to GAT107. Our data show that both orthosteric and allosteric activation of α7 nAChR require cooperative activity at the interface between the subunits in the extracellular domain. These cooperative effects rely on key aromatic residues, and although mutations of Trp-55 reduce the restraints placed on the requirement for orthosteric agonists, Tyr-93 can conduct both orthosteric activation and desensitization among the subunits. 相似文献